(PHRM.L) Phorm Inc Buy/Sell

RNS Number : 9523B Phorm Inc 04 November 2009

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuer of existing Phorm Inc.

shares to which voting rights are attached:

2 Reason for the notification (please tick the appropriate box or boxes):
X

An acquisition or disposal of voting rights An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments An event changing the breakdown of voting rights
Disclosure of holdings follows the sale of Insight Investment Management X
Other (please specify): Limited on 2 November 2009. This notification supersedes any notifications
previously issued by Lloyds Banking Group plc.
3. Full name of person(s) Lloyds Banking Group plc

subject to the notification obligation:

4. Full name of shareholder(s) See Section 9. (if different from 3.):

5. Date of the transaction and 02 November 2009 date on which the threshold is crossed or reached:

6. Date on which issuer 04 November 2009

notified:

7. Threshold(s) that is/are N/A - Direct/Indirect
crossed or reached: holdings remain above 5%

8. Notified details: A: Voting rights attached to shares

Class/type of Situation previous Resulting situation after the triggering transaction
shares to the triggering
transaction

if possible using the ISIN CODE
Number Number Number Number of voting % of voting rights
of of of shares rights
Shares Voting
Rights
Direct Direct Indirect Direct Indirect
Common Stock USD0.001 949,373 949,373 462,838 462,838 506,535 2.754% 3.014%

B: Qualifying Financial Instruments Resulting situation after the triggering transaction

Type of financial Expiration Exercise/ Number of voting % of voting
instrument date Conversion rights that may be rights
Period acquired if the
instrument is
exercised/
converted.

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments Resulting situation after the triggering transaction

Type of financial Exercise Expiration Exercise/ Number of voting % of voting rights
instrument price date Conversion rights instrument
period refers to
Nominal Delta

Total (A+B+C)

Number of voting rights Percentage of voting rights
969,373 5.769%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: 908,686 shares (5.408%) are under the control of Scottish Widows Investment Partnership Ltd, a wholly owned subsidiary of Scottish Widows Group Ltd, a wholly owned subsidiary of Lloyds TSB Bank plc, a wholly owned subsidiary of Lloyds Banking Group plc (Direct/Indirect Interests).

Proxy Voting:

10. Name of the proxy holder: N/A
11. Number of voting rights proxy holder will cease to hold: N/A

12. Date on which proxy holder will cease to hold voting rights: N/A

13. Additional information: Notification using the Total Voting Rights
figure of 16,803,649
14. Contact name: Matthew Wilson

15. Contact telephone number: 0113 235 7729

This information is provided by RNS The company news service from the London Stock Exchange

HOLEALFLEFKNFFE